Why the drug development pipeline is not delivering better medicines

Naci, HuseyinORCID logo; Carter, Alexander W.; and Mossialos, EliasORCID logo (2015) Why the drug development pipeline is not delivering better medicines BMJ, 351. ISSN 1756-1833
Copy

Despite the large number of new medicines entering the market every year, the vast majority offer few clinical advantages for patients over existing alternatives. Governments and pharmaceutical companies share the responsibility for this innovation deficit in the sector.
Item Type Article
Departments LSE Health
DOI 10.1136/bmj.h5542
Date Deposited 29 Oct 2015 11:56
URI https://researchonline.lse.ac.uk/id/eprint/64220

Explore Further

picture_as_pdf
subject
Accepted Version
Download

Atom BibTeX OpenURL ContextObject in Span OpenURL ContextObject Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation METS MODS RIOXX2 XML Reference Manager Refer ASCII Citation
Export

Downloads